Metraipolis › archive › dc_eafc9ff4b5ed

Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel — Europe PMC PMID:41545709

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41545709
DOI
10.1038/s41433-[numero omesso]-8
License (as archived)
solo-consultazione
Archived
2026-11-06T18:06:18.138Z
SHA-256 of the archived text
e3346e4b1fd2e46d71945b1f26fd01e7d33312f7be8390a59d5d9f4fa441f55d
Stable URL of this page
https://metraipolis.com/documento/dc_eafc9ff4b5ed

How to cite

Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel — Europe PMC PMID:41545709 — Europe PMC (en), https://europepmc.org/article/MED/41545709 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eafc9ff4b5ed (Metraipolis archive dc_eafc9ff4b5ed, sha256 e3346e4b1fd2e46d71945b1f26fd01e7d33312f7be8390a59d5d9f4fa441f55d)
BibTeX
@misc{dceafc9ff4b5ed,
  title = {Aflibercept 8 mg treat-and-extend pathway for the treatment of neovascular age-related macular degeneration: guidance from a UK expert panel — Europe PMC PMID:41545709},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41545709},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eafc9ff4b5ed; sha256 e3346e4b1fd2e46d71945b1f26fd01e7d33312f7be8390a59d5d9f4fa441f55d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41545709. Agents can read the archived copy with the MCP tool read_document.